Finance

Lists
Why is SDPC down 2.56%?
Dive Deeper
SDPC:IDX
Millennium Pharmacon Internationl Tbk PT
IDR 190.00
-2.56%
(-5.00) 1D
Nov 6, 3:19:54 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SDPC...
Open
IDR 192
High
IDR 197
Low
IDR 184
Mkt. cap
242.06B
Avg. vol.
744.33K
Volume
264.30K
Dividend
1.58%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 8, 2026
P/E ratio
5.86
52-wk high
IDR 228
52-wk low
IDR 135
EPS
IDR 32
Shares outstanding
1.27B
No. of employees
1K
Open
IDR 192
High
IDR 197
Low
IDR 184
Mkt. cap
242.06B
Avg. vol.
744.33K
Volume
264.30K
Dividend
1.58%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 8, 2026
P/E ratio
5.86
52-wk high
IDR 228
52-wk low
IDR 135
EPS
IDR 32
Shares outstanding
1.27B
No. of employees
1K
News stories
From web sources and news partners
About Millennium Pharmacon Internationl Tbk PT
CEO-
Employees1.2K
Founded1952
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitempi-indonesia.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.11T
1.02T
1.11T
1.15T
Cost of goods sold
1.00T
930.34B
1.02T
1.05T
Cost of revenue
1.00T
930.34B
1.02T
1.05T
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.14B
58.04B
62.13B
64.76B
Operating expense
71.31B
59.44B
62.19B
68.39B
Total operating expenses
1.07T
989.78B
1.08T
1.12T
Operating income
33.66B
28.19B
32.27B
32.59B
Other non operating income
-
-
-
363.31M
EBT including unusual items
21.04B
13.11B
15.00B
13.20B
EBT excluding unusual items
21.04B
13.11B
15.00B
13.20B
Income tax expense
2.95B
3.00B
5.55B
2.34B
Effective tax rate
14.05%
22.91%
36.97%
17.71%
Other operating expenses
10.17B
1.40B
61.09M
3.62B
Net income
18.08B
10.10B
9.46B
10.87B
Net profit margin
1.63%
0.99%
0.85%
0.95%
Earnings per share
-
-
-
-
Interest and investment income
45.33M
37.63M
59.17M
-
Interest expense
-12.67B
-15.12B
-17.32B
-19.75B
Net interest expenses
-12.63B
-15.09B
-17.26B
-19.75B
Depreciation and amortization charges
-
-
-
-
EBITDA
36.39B
29.93B
33.89B
34.21B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps